Abstract:Abstract Background Brachyspira hyodysenteriae is the primary cause of swine dysentery, characterized by bloody to mucoid diarrhea due to mucohaemorhagic colitis in pigs and primarily affects pigs during the grow/finishing stage. Control and prevention of B. hyodysenteriae consists of administration of antimicrobial drugs, besides management and adapted feeding strategies. A worldwide re-emergence of the disease has recently been reported with an increasing number of isolates demonstrating decreased susceptibility to several crucially important antimicrobials in the control of swine dysentery. A novel non-antibiotic zinc chelate has been reported to demonstrate positive effects on fecal quality and consistency, general clinical signs, average daily weight gain and B. hyodysenteriae excretion during and after a 6-day oral treatment. The objective of the present study was to evaluate the zinc chelate (Intra Dysovinol ® 499 mg/ml (ID); Elanco) on naturally occurring swine dysentery due to B. hyodysenteriae under field conditions in the Netherlands. Results Oral administration of zinc chelate resulted in improvement of general clinical signs from 3 days onwards in the ID-treated group combined with a significantly better total fecal score at 14 days post-treatment. Overall, average daily weight gain was better in the ID-treated group over the entire study period (0–14 days) and during the 8 days following the end of ID-treatment. A significant reduction (4.48 vs. 0.63 log 10 cfu/g feces; ID-treated vs. control) in B. hyodysenteriae excretion was observed during the 6-day treatment period with a high percentage of animals (58.3 vs. 12.3%; ID-treated vs. control) with no excretion of B. hyodysenteriae from their feces. No additional antimicrobial treatment was needed in the ID-treated group, whereas 35% of the pigs in the control group were treated with an antibiotic at least once. No mortality occurred in both groups. No adverse events were reported during and following the ID-treatment. Conclusions Zinc chelate – administered as a Zn-Na 2 -EDTA complex – is a non-antibiotic treatment for swine dysentery that reduces B. hyodysenteriae shedding with 4.48 log 10 cfu/g feces within its 6-day treatment while improving general clinical signs (90.0 vs. 73.6% animals with normal score) and total fecal score within 2–4 days following administration in naturally infected pigs. The positive effects of ID treatment remain for at least 8 days after cessation of oral ID therapy. Pigs remaining in a highly contaminated environment may be re-infected following the end of ID treatment, however, this is not different to standard antimicrobial therapy. Therefore, control of swine dysentery should combine an efficacious treatment with additional management practices to reduce the environmental infection pressure in order to limit re-infection as much as possible. The ID treatment resulted in a higher growth rate and improved general health, whereas no mortality was observed and no additional therapeutic treatments were necessary in contrast to the control pigs.

Testing the efficacy of kitasamycin for use in the control and treatment of swine dysentery in experimentally infected pigs

Experimental Infection of Pigs with a ST 245 Brachyspira hyodysenteriae Isolated from an Asymptomatic Pig in a Herd with No History of Swine Dysentery

PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin Against Streptococcus Suis in Piglets

Pharmacokinetic and Pharmacodynamic Integration and Modeling of Acetylkitasamycin in Swine for Clostridium Perfringens

Antimicrobial susceptibility of Brachyspira hyodysenteriae isolated from 21 Polish farms

Treatment of clinical Brachyspira hyodysenteriae with zinc chelate in pigs: a blinded, randomised controlled trial

Antibacterial Activity of Combined Aditoprim and Sulfamethoxazole Against Escherichia Coli from Swine and a Dose Regimen Based on Pharmacokinetic-Pharmacodynamic Modeling

New insights into swine dysentery: faecal shedding, macro and microscopic lesions and biomarkers in early and acute stages of Brachyspira hyodysenteriae infection

Influences of diet and vaccination on colonisation of pigs by the intestinal spirochaete Brachyspira (Serpulina) pilosicoli

Effect of Direct-Fed Microbial Bacillus Subtilis C-3102 on Enteric Health in Nursery Pigs after Challenge with Porcine Epidemic Diarrhea Virus

Subtherapeutic Kitasamycin Promoted Fat Accumulation in the Longissimus Dorsi Muscle in Growing–Finishing Pigs

Subclinical colitis associated with moderately hemolytic Brachyspira strains

Evaluation of a zinc chelate on clinical swine dysentery under field conditions

Effect of antibiotic treatment on Mycoplasma hyopneumoniae detection and infectious potential

Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs

Efficacy of Enteric-Coated Tilmicosin Granules in Pigs Artificially Infected with Actinobacillus Pleuropneumoniae Serotype 2

Brachyspira hyodysenteriae Infection Reduces Digestive Function but Not Intestinal Integrity in Growing Pigs While Disease Onset Can Be Mitigated by Reducing Insoluble Fiber

An optimized swine dysentery murine model to characterize shedding and clinical disease associated with “Brachyspira hampsonii” infection

Investigation of the Efficiency and Safety of Tilmicosin Phosphate in Treating Experimental Mycoplasmal Infections in Pigs

Efective Combination of Doxyvet and Tiamutin for Bacterial Diseases Prevention in Weaning Pigs

Colonic innate immune defenses and microbiota alterations in acute swine dysentery